Masuda et al. indicated that CHODL was overexpressed in non-small-cell lung cancer (NSCLC), which contributed to a poor prognosis in patients, and the exogenous transfection of CHODL into a lung cancer cell line enhanced cell growth and invasion 12. The gene discussed is CHODL; the disease is non-small cell lung carcinoma.